Protein phosphatase 5 as a negative key regulator of Raf-1 activation
- PMID: 17084641
- DOI: 10.1016/j.tem.2006.10.013
Protein phosphatase 5 as a negative key regulator of Raf-1 activation
Abstract
Growth factors such as the epidermal growth factor cause sequential activation of receptor tyrosine kinases, adaptor molecules and the Raf-MEK-ERK pathway. The kinetics and intensity of these signals are dependent on the balance between phosphorylation and dephosphorylation of these molecules by numerous kinases and phosphatases, respectively. Recently, protein phosphatase 5 has been characterized as a key dephosphorylation regulator of Raf-1 activation in growth factor-mediated signaling, leading to attenuation of the MEK-ERK cascade.
Similar articles
-
Collagen type I-mediated activation of ERK/MAP Kinase is dependent on Ras, Raf-1 and protein phosphatase 2A in Jurkat T cells.Mol Immunol. 2006 Apr;43(10):1687-93. doi: 10.1016/j.molimm.2005.09.010. Epub 2005 Nov 2. Mol Immunol. 2006. PMID: 16266749
-
B-Raf and C-Raf signaling investigated in a simplified model of the mitogenic kinase cascade.Biol Chem. 2005 Nov;386(11):1165-71. doi: 10.1515/BC.2005.133. Biol Chem. 2005. PMID: 16307482
-
Id-1-induced Raf/MEK pathway activation is essential for its protective role against taxol-induced apoptosis in nasopharyngeal carcinoma cells.Carcinogenesis. 2004 Jun;25(6):881-7. doi: 10.1093/carcin/bgh087. Epub 2004 Jan 23. Carcinogenesis. 2004. PMID: 14742319
-
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.Oncogene. 2007 May 14;26(22):3291-310. doi: 10.1038/sj.onc.1210422. Oncogene. 2007. PMID: 17496923 Review.
-
Hyperactive Ras in developmental disorders and cancer.Nat Rev Cancer. 2007 Apr;7(4):295-308. doi: 10.1038/nrc2109. Nat Rev Cancer. 2007. PMID: 17384584 Review.
Cited by
-
Cytokine-Induced Glucocorticoid Resistance from Eosinophil Activation: Protein Phosphatase 5 Modulation of Glucocorticoid Receptor Phosphorylation and Signaling.J Immunol. 2016 Nov 15;197(10):3782-3791. doi: 10.4049/jimmunol.1601029. Epub 2016 Oct 14. J Immunol. 2016. PMID: 27742828 Free PMC article.
-
PPP5C promotes cell proliferation and survival in human prostate cancer by regulating of the JNK and ERK1/2 phosphorylation.Onco Targets Ther. 2018 Sep 12;11:5797-5809. doi: 10.2147/OTT.S161280. eCollection 2018. Onco Targets Ther. 2018. PMID: 30254472 Free PMC article.
-
NRF2, a Key Regulator of Antioxidants with Two Faces towards Cancer.Oxid Med Cell Longev. 2016;2016:2746457. doi: 10.1155/2016/2746457. Epub 2016 Jun 2. Oxid Med Cell Longev. 2016. PMID: 27340506 Free PMC article. Review.
-
Elevated levels of Ser/Thr protein phosphatase 5 (PP5) in human breast cancer.Biochim Biophys Acta. 2008 Apr;1782(4):259-70. doi: 10.1016/j.bbadis.2008.01.004. Epub 2008 Jan 26. Biochim Biophys Acta. 2008. PMID: 18280813 Free PMC article.
-
Disruption of serine/threonine protein phosphatase 5 inhibits tumorigenesis of urinary bladder cancer cells.Int J Oncol. 2017 Jul;51(1):39-48. doi: 10.3892/ijo.2017.3997. Epub 2017 May 16. Int J Oncol. 2017. PMID: 28534961 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous